UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ | --- | --- | --- | --- | --- | --- | |---- ...

| --- | --- | |---------------------------------------------------------------|-------| | | | | | | | | | | Evolent Health Fourth Quarter 2021 Results February 23, 2022 | | | | | | | | Safe Harbor Statement Certain statements made in this report and in other written or oral statements made by us or on our behalf are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). A forward-looking statement is a statement that is not a historical fact and, w ...

Evolent Health, Inc. (NYSE:EVH) Q4 2021 Results Conference Call February 23, 2022 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Seth Frank - Vice President of Investor Relations Conference Call Participants Ryan Daniels - William Blair Anne Samuel - JPMorgan Charles Rhyee - Cowen David Larsen - BTIG Matthew Shea - Piper Sandler Operator Welcome to Evolent Health's Earnings Conference Call for the Fourth Quarter and Year ended December 31, 2021 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-K _________________________ (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | --- | --- | --- | |------------------|-------------------------------------------------- ...

Evolent Health, Inc. (NYSE:EVH) Q3 2021 Earnings Conference Call November 3, 2021 5:30 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Sean Wieland - Piper Sandler Charles Rhyee - Cowen Inc. David Larsen - BTIG, LLC Operator Welcome to Evolent Health Earnings Conference Call for the Quarter Ended September 30, 2021. As a reminder, this conference call is being recorded. Your host for the call ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ | --- | --- | --- | --- | --- | --- | | ...

Evolent Health, Inc. (NYSE:EVH) Q2 2021 Earnings Conference Call August 4, 2021 6:00 PM ET Company Participants Seth Blackley - Co-Founder, CEO & Director John Johnson - CFO Conference Call Participants Ryan Daniels - William Blair & Company Charles Rhyee - Cowen and Company Richard Close - Canaccord Genuity David Larsen - BTIG Sean Wieland - Piper Sandler & Co. Operator Welcome to Evolent Health's Earnings Conference Call for the Quarter Ended June 30, 2021. As a reminder, this conference call is being rec ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ | --- | --- | --- | --- | --- | --- | |----- ...

| --- | --- | |-----------------------------|-------| | | | | | | | Bank of America Conference: | | | Evolent Health May 13, 2021 | | | | | | | | Safe Harbor Statement Certain statements in this presentation and in other written or oral statements made by us or on our behalf are "forward-lookingstatements" within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any stateme ...

Evolent Health, Inc. (NYSE:EVH) Q1 2021 Results Conference Call May 5, 2021 6:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Robert Jones - Goldman Sachs Sean Wieland - Piper Sandler Charles Rhyee - Cowen Anne Samuel - JP Morgan Richard Close - Canaccord Genuity Sandy Draper - Truist Securities David Larsen - BTIG Operator Welcome to Evolent Health's earnings conference call for the quarte ...